Search
Osoresnontrine
go.drugbank.com/drugs/DB16274InvestigationalOsoresnontrine is under investigation in clinical trial NCT02281773 (A Study to Investigate the Efficacy, Safety and Tolerability of Four Different Doses of BI 409306 Compared to Placebo Given for 12 Weeks
Ceftezole
go.drugbank.com/drugs/DB13821InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseCefbuperazone
go.drugbank.com/drugs/DB13638ExperimentalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UseCefatrizine
go.drugbank.com/drugs/DB13266InvestigationalCategories: Antibacterials for Systemic Use, Antiinfectives for Systemic UsePlozasiran
go.drugbank.com/drugs/DB18997ApprovedInvestigationalPlozasiran (ARO-APOC3) is a small interfering RNA (siRNA) that degrades apolipoprotein C-III (apoC-III) mRNA by RNA interference. Plozasiran contains a covalently linked ligand containing three N-acetylgalactosamine (GalNAc) residues to ...
CX501
go.drugbank.com/drugs/DB05174InvestigationalCx501 is used to treat epidermolysis bullosa (EB), a rare genetic condition which can lead to contraction of the joints, fusion of fingers and toes, contraction of the mouth membranes and narrowing of the oesophagus. It is developed by C...
Goflikicept
go.drugbank.com/drugs/DB16396InvestigationalGoflikicept is under investigation in clinical trial NCT04380519 (Study of the Efficacy and Safety of a Single Administration of Olokizumab and RPH-104 With Standard Therapy in Patients With Severe Severe Acute Respiratory Syndrome Coron...
Categories: Experimental Unapproved Treatments for COVID-19Decyl(dimethyl)phosphine oxide
go.drugbank.com/drugs/DB07641ExperimentalCategories: Monoamine Oxidase A Inhibitors for interaction with Monoamine Oxidase A substratesBMN-351
go.drugbank.com/drugs/DB18186InvestigationalIt is under investigation for the treatment of Duchenne Muscular Dystrophy (DMD).
Insulin efsitora alfa
go.drugbank.com/drugs/DB19013Investigationalalfa is under investigation in clinical trial NCT05662332 (A Study of Insulin Efsitora Alfa (LY3209590) Compared to Glargine in Adult Participants With Type 2 Diabetes Who Are Starting Basal Insulin for